RxDoctor Payments Data

Lea Bryan

Nurse Practitioner · Edmond, OKNPI 1073020988

Payments from drug & device makers

$2,051in general payments, 2019–2025

Across 132 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$695
  • Teva Pharmaceuticals USA, Inc.$214
  • Kyowa Kirin, Inc.$158
  • Amneal Pharmaceuticals LLC$143
  • AbbVie$108
  • Abbott$100
  • plus $633 from 18 others

What the payments were for

  • Speaking & faculty fees$653%
  • Food & beverage$1,98597%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,051 in reported general payments places this provider in the 85th percentile of 824 nurse practitioner providers in Oklahoma.

See all nurse practitioner providers in Oklahoma

Medicare billing

Part B allowed, 2024
$36,479
Medicare patients
104
Services billed
3,093

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate12$59,975
Aimovig AutoinjectorErenumab-Aooe21$22,742
Emgality PenGalcanezumab-Gnlm11$7,569
Lacosamide14$1,648
Carbidopa-Levodopa ErCarbidopa/Levodopa12$749
Carbidopa-LevodopaCarbidopa/Levodopa41$621
Candesartan Cilexetil11$427
Pregabalin24$376
Gabapentin34$361
Zonisamide21$350
Levetiracetam20$324
Duloxetine Hcl20$234
Sumatriptan Succinate27$223
Amitriptyline Hcl29$184
Quetiapine Fumarate11$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$695$59,97512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 824 nurse practitioner providers in Oklahoma.

Other nurse practitioner in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →